The CA 19-9 Tumor Marker: What it Means in Pancreatic Cancer

Discover the role of CA 19-9 as a tumor marker in pancreatic cancer, including what elevated levels signify, its limitations for diagnosis, and how it's used for monitoring treatment response and prognosis. Learn why CA 19-9 isn't a standalone diagnostic tool, the impact of benign conditions like jaundice, the Lewis-negative phenotype affecting 5-10% of people, and the value of serial measurements for detecting recurrence early. This video breaks down sensitivity, specificity, and practical advice for patients and clinicians on interpreting results accurately.


This content is entirely based on medical research and evidence. Content carefully curated by Mr Saboor Khan PhD FRCS FACS (Consultant Surgeon).

Explore the full video series for a broader understanding of your condition with evidence-based content; check out the playlist below.

Educational Disclaimer: This content is for information only and personal medical decisions must be made with the treating team. Patients may not draw inferences about their own condition from this content. Every effort is being made that the content is current at the time of production, however, this cannot be guaranteed.